NIDA to Fund Studies of Genetic Variation in Drug Abuse and Addiction | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute of Drug Abuse will fund researchers studying how genetic variation affects drug abuse and drug addition, and resistance for drugs commonly abused, such as psychostimulants, opiates, nicotine, and marijuana.
 
In an effort to better understand abuse phenotypes by studying underlying genetic factors, NIDA plans to spend $2 million to fund between eight and ten grantees over the next two years in the “Behavioral Pharmacology and Genetics: Translating Individual Differences” program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.